Revenue (Tables)

3 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	Three Months Ended March 31,
	2023	2022
Biologics	34 %	43 %
Generics	20 %	17 %
Pharma	27 %	24 %
Contract-Manufactured Products	19 %	16 %
	100 %	100 %

The following table presents the approximate percentage of our net sales by product category:

	Three Months Ended March 31,
	2023	2022
High-Value Product Components	51 %	56 %
High-Value Product Delivery Devices	7 %	5 %
Standard Packaging	23 %	23 %
Contract-Manufactured Products	19 %	16 %
	100 %	100 %

The following table presents the approximate percentage of our net sales by geographic location:

	Three Months Ended March 31,
	2023	2022
Americas	44 %	45 %
Europe, Middle East, Africa	47 %	45 %
Asia Pacific	9 %	10 %
	100 %	100 %

Schedule of Change in Contract With Customer, Asset and Liability

The following table summarizes our contract assets and liabilities, excluding amounts included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2022	$	16.3
Contract assets, March 31, 2023	19.4
Change in contract assets - increase (decrease)	$	3.1
Deferred income, December 31, 2022	$	(68.2)
Deferred income, March 31, 2023	(57.5)
Change in deferred income - decrease (increase)	$	10.7